JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z, 12Z-octadecadienoyl)-sn-
glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC (= O) OC [C …

Monoclonal anti-tumor antibodies (mAbs) that are clinically effective usually recruit, via their
constant fragment (Fc) domain, Fc receptor (FcR)-positive accessory cells of the immune …

Redirecting the immune system to eliminate tumor cells is a promising alternative to
traditional cancer therapies, most often requiring direct interaction between an immune …

The DOCK-AND-LOCKTM (DNLTM) method provides a modular approach to develop
multivalent, multifunctional complexes of defined structures, of which bispecific hexavalent …

This invention relates to agents that are inhibitors or activa tors of variant forms of
endogenous proteins and novel meth ods of identifying Such variants. Of particular interest …

DZGOZELMFRSXME-KVSWJAHQSA-N O= C (NC1= CC= CC (C (F)(F) F)= C1) C1= CC=
CC (/C= N/NC2= NC (N3CCOCC3)= C (F) C= N2)= N1 Chemical compound O= C (NC1 …

Biopharmaceutical production through transient gene expression (TGE) is used within
industry for the rapid supply of product for early stage testing. A key requirement of the …

Abstracts Advances in antibody engineering technologies have resulted in a number of
novel biopharmaceutical formats capable of binding to multiple targets. This flexibility …

The most common primary malignant brain tumor, glioblastoma, is uniformly fatal. Current
therapy provides only incremental benefits in survival and is often incapacitating owing to …

Chimärisierte und humanisierte monoklonale Antikörper der zweiten Generation haben die
Therapie und Prognose einiger malignen Erkrankungen bereits stark verbessert. In vielen …